managing polypharmacy: thinking outside the [dosette] box

54
Managing Polypharmacy: Thinking outside the [dosette] box Martin Wilson Consultant Physician Care of the Elderly NHS Highland

Upload: others

Post on 23-May-2022

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Managing Polypharmacy: Thinking outside the [dosette] box

Managing Polypharmacy:Thinking outside the [dosette] box

Martin Wilson

Consultant Physician

Care of the Elderly

NHS Highland

Page 2: Managing Polypharmacy: Thinking outside the [dosette] box

What are we going to do?

• A quick run through core principles and challenges in Polypharmacy Management

• Example from the receiving unit

Page 3: Managing Polypharmacy: Thinking outside the [dosette] box

Disclaimers

• Stopping drugs is not the primary goal

• Thinking openly and carefully is the goal

Page 4: Managing Polypharmacy: Thinking outside the [dosette] box

Three overlapping areas

Multimorbidity Frailty

Polypharmacy

Page 5: Managing Polypharmacy: Thinking outside the [dosette] box

Multimorbidity

Page 6: Managing Polypharmacy: Thinking outside the [dosette] box

Barnett K, Mercer SW, Norbury M et al. Epidemiology of multi-morbidity and implications for healthcare, research, and medical education: a cross sectional study. The Lancet

2012:380:37-43

Multimorbidity is common

Page 7: Managing Polypharmacy: Thinking outside the [dosette] box

Multimorbidity

Polypharmacy

Page 8: Managing Polypharmacy: Thinking outside the [dosette] box

ISD

Page 9: Managing Polypharmacy: Thinking outside the [dosette] box

Source ISD

Page 10: Managing Polypharmacy: Thinking outside the [dosette] box

Multimorbidity Frailty

Polypharmacy

Page 11: Managing Polypharmacy: Thinking outside the [dosette] box

0

10

20

30

40

50

60

70

80

90

100

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 55 57 59 61

Functional history as important as Past Medical History

Page 12: Managing Polypharmacy: Thinking outside the [dosette] box

Steady Dwindiling

0

10

20

30

40

50

60

70

80

90

100

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Page 13: Managing Polypharmacy: Thinking outside the [dosette] box

Clegg et al. Frailty in elderly people. The Lancet, Vol 361, Issue 9868, 2013,752-762

Page 14: Managing Polypharmacy: Thinking outside the [dosette] box

So how old is your patient?

• Lots of old folk who are physiologically younger than years

– Most of whom will be rich

• Lots of younger folk who are physiologically older than years

– Many of whom be deprived

Page 15: Managing Polypharmacy: Thinking outside the [dosette] box

What category is your patient in?

Multimorbidity

Frail

Polypharmacy

FrailPolypharmacy

Multimorbidity PolypharmacyFrail

Page 16: Managing Polypharmacy: Thinking outside the [dosette] box

What category is your patient in?

Multimorbidity

Frail

Polypharmacy

Frail Polypharmacy

Multimorbidity Polypharmacy Frail

Page 17: Managing Polypharmacy: Thinking outside the [dosette] box
Page 18: Managing Polypharmacy: Thinking outside the [dosette] box

0

10

20

30

40

50

60

70

80

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 55 57 59

0

10

20

30

40

50

60

70

80

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 55 57 59

Stroke

Diagnosed

Diabetes Vascular

Dementia

COPD

Fall and

Lumbar

vertebral

fracture

Hospital

Admission

Recurrent

UTIs

MI

Page 19: Managing Polypharmacy: Thinking outside the [dosette] box

Medication

• Metformin 1 g TDS

• Gliclazide 160mg bd

• Calcichew D3 forte 1 tab twice a day

• Alendronate 70mg once a week

• Perindopril 4mg once a day

• Indapamide 2.5mg once a day

• Seretide 250 1 puff twice a day

• Apixiban 5 mg twice a day

• Salbutamol as required

• Ipratropium Inhaler 4 times a day

• Clopidogrel 75mg once a day

• Atorvastatin 80mg once a day

• Mirtazapine 30mg nocte

• Zopicolone 7.5 mg at night

• Oxybutinin 5mg bd

• Thyroxine 150mcg once a day

• Ipratropium inhaler 4 times a day.

• Paracetamol 1g QDS

• Omeprazole 20mg once a day

• Trimethoprim 200mg once a day prophylaxis

Page 20: Managing Polypharmacy: Thinking outside the [dosette] box

Medication

• DIABETES– Metformin 1 g TDS– Gliclazide 160mg bd

• OSTEOPOROSIS– Calcichew D3 forte 1 tab twice a

day– Alendronate 70mg once a week

• POST CVA– Perindopril 4mg once a day– Indapamide 2.5mg once a day– Apixiban 5 mg twice a day

• COPD– Seretide 250 1 puff twice a day– Salbutamol as required – Atrovent inhaler 4 times a day

• POST MI– Clopidogrel 75mg once a day– Atorvastatin 80mg once a day

• MOOD /BEHAVIOUR– Mirtazapine 30mg nocte– Zopicolone 7.5 mg at night

• BLADDER– Oxybutinin 5mg bd

• ENDOCRINE– Thyroxine 150mcg once a day

• OTHER– Paracetamol 1g QDS– Omeprazole 20mg once a day– Trimethoprim 200mg once a day

prophylaxis

Page 21: Managing Polypharmacy: Thinking outside the [dosette] box
Page 22: Managing Polypharmacy: Thinking outside the [dosette] box

Emergency admission

• Crushing central chest pain at home

• Sweaty and clammy

• Resolved after morphine

• Now up and about on the ward. Confused looking for husband

Page 23: Managing Polypharmacy: Thinking outside the [dosette] box

Tests

• Troponin >> lots

• ECG > Deep inverted anterior T waves/ AF (old)

• Chest X ray > mild congestion (but poor film)

• BP 98/40

• Urea 10 Creat 132

– Baseline Urea 8 / Creat 124

• WBC 8.6 Hb 98 MCV 92 Plat 140

Page 24: Managing Polypharmacy: Thinking outside the [dosette] box

Diagnosis

• Acute Coronary Syndrome

• Delirium

Page 25: Managing Polypharmacy: Thinking outside the [dosette] box

Management

• Cardiology

– Medical Management would not angio

– ECHO if tolerated

• Nursing

– Up and about a lot increasingly distressed

Page 26: Managing Polypharmacy: Thinking outside the [dosette] box

So what is ‘medical management’ here ?

• Fondaparinux /Clopidogrel /Aspirin /Apixiban

– NO!

• Aspirin and Clopidogrel and Fondaparinux

• Clopidogrel and Apixiban

• Aspirin and Apixiban

• Aspirin and Clopidogrel

• Clopidogrel

• Aspirin

• ????

Page 27: Managing Polypharmacy: Thinking outside the [dosette] box

How do guidelines help us manage these groups?

Page 28: Managing Polypharmacy: Thinking outside the [dosette] box

Honesty about Guidelines

• Done with a SINGLE disease in mind

• Based on studies in non- frail

• Are not made with the frail or multimorbid in mind

• They are GUIDElines but– Can be VERY hard to ‘defy’ them

Page 29: Managing Polypharmacy: Thinking outside the [dosette] box

• Almost no trial evidence in frail adults

– Different pharmacology

– Huge comorbidity

• Use the best we have ie younger adults

– Different Absolute Risk

– Different Harm rates.

Page 30: Managing Polypharmacy: Thinking outside the [dosette] box

• Almost no trial evidence in frail adults

– Different pharmacology

– Huge comorbidity

• Use the best we have ie younger adults

– Different Absolute Risk

– Different Harm rates.

Page 31: Managing Polypharmacy: Thinking outside the [dosette] box

Why did you jump off a cliff?

Because the Guideline told me to.

Page 32: Managing Polypharmacy: Thinking outside the [dosette] box

Game changing concepts

If guideline says Prescribe X drug it is GUIDANCE not INSTRUCTION and not prescribing may well be acceptable (and often desirable) in a range of situations

One size does not fit all.....

Page 33: Managing Polypharmacy: Thinking outside the [dosette] box

Beware Extrapolation

Page 34: Managing Polypharmacy: Thinking outside the [dosette] box

Rivaroxaban with or without Aspiring in Stable Cardiovascular Disease Eikelboom et al NEJM

2017; 377 (14) 1319 - 1330

Page 35: Managing Polypharmacy: Thinking outside the [dosette] box

Comparative effectiveness of high-dose versus standard-dose influenza vaccination on

numbers of US nursing home residents admitted to hospital: a cluster-randomised trial

Gravenstein S et al., Lancet Respir Med. 2017;5(9):738-46).

Page 36: Managing Polypharmacy: Thinking outside the [dosette] box
Page 37: Managing Polypharmacy: Thinking outside the [dosette] box

– What are the patients priorities likely to be?

– What are there carers priorities likely to be?

– What are the Health Service Priorities likely to be?

Page 38: Managing Polypharmacy: Thinking outside the [dosette] box

Medication

• Metformin 1 g TDS

• Gliclazide 160mg bd

• Calcichew D3 forte 1 tab twice a day

• Alendronate 70mg once a week

• Perindopril 4mg once a day

• Indapamide 2.5mg once a day

• Seretide 250 1 puff twice a day

• Salbutamol as required

• Ipratropium Inhaler 4 times a day

• Clopidogrel 75mg once a day

• Atorvastatin 80mg once a day

• Mirtazapine 30mg nocte

• Zopicolone 7.5 mg at night

• Oxybutinin 5mg bd

• Thyroxine 150mcg once a day

• Ipratropium inhaler 4 times a day.

• Paracetamol 1g QDS

• Omeprazole 20mg once a day

• Trimethoprim 200mg once a day prophylaxis

Page 39: Managing Polypharmacy: Thinking outside the [dosette] box

Medication in the Frailest Adults

• Blood pressure - avoid blood pressure < 130 systolic and or < 65 diastolic [except in LVSD]

• Blood sugar control - avoid lowering HbA1c < 65

• Treatments to maintain renal function and avoid progression of proteinuria - avoid treating unless considered to have sufficient life expectancy to see benefit

• Use of blood thinners - avoid the use of combination blood thinners

• Heart rate control - reduce or stop heart rate limiting medication if pulse < 60

Polypharmacy Guidance, Realistic Prescribing 3rd Edition, 2018. Scottish

Government Polypharmacy Model of Care Group.

Page 40: Managing Polypharmacy: Thinking outside the [dosette] box

This lady

• Aspirin or Clopidogrel alone

• A lot less of her other medication….

Page 41: Managing Polypharmacy: Thinking outside the [dosette] box

Facts and figures• BP 106/56

• HbA1c 40 mmmol/mol 5.8%

• Urine Albumin/Creat ratio – trace microalbuminuria

• Creatinine 124 eGFR 45

• ECG Atrial Fibrillation 62 bpm

• Weight 43kg

Page 42: Managing Polypharmacy: Thinking outside the [dosette] box
Page 43: Managing Polypharmacy: Thinking outside the [dosette] box
Page 44: Managing Polypharmacy: Thinking outside the [dosette] box
Page 45: Managing Polypharmacy: Thinking outside the [dosette] box
Page 46: Managing Polypharmacy: Thinking outside the [dosette] box

?

Page 47: Managing Polypharmacy: Thinking outside the [dosette] box

?

Page 48: Managing Polypharmacy: Thinking outside the [dosette] box

?

Page 49: Managing Polypharmacy: Thinking outside the [dosette] box

?

Page 50: Managing Polypharmacy: Thinking outside the [dosette] box

?

Page 51: Managing Polypharmacy: Thinking outside the [dosette] box

?

Page 52: Managing Polypharmacy: Thinking outside the [dosette] box

?

Page 53: Managing Polypharmacy: Thinking outside the [dosette] box

• [Postural] Blood Pressure too low ?

• Blood Sugar too low?

• Blood too thin [ed]?

• Kidneys too vulnerable?

• Any Messy drugs ?

Page 54: Managing Polypharmacy: Thinking outside the [dosette] box

Three Take Home Messages

• Addressing Polypharmacy begins and ends with individualised patient defined goals

• Frailty is a more useful concept than chronological age

• Better knowledge of efficacy and risk can aid decision making